Pediatric oncology Clinical interventions Quality of life and care Psychosocial outcomes Big data Population-based research Cancer origins Drug targets Immuno-therapy

Both a research funder and patient advocacy organization. In addition to funding research projects they fund emotional, financial and logistical support to childhood cancer families to help make their challenges more manageable. Childhood Cancer Research Program Areas: - Early Career Research: --- 'A' Award Grants: funds an original project, can demonstrate outstanding career development support from the institution, and has a strong future commitment to pediatric cancer investigation. $200K

Basic, translational, clinical, population research

AACR grants support researchers domestically and abroad at every stage of their careers, from early-career investigators and mid-career researchers to senior scientists. In 2022, the AACR awarded more than $10.3 million in grants.

Immunotherapy Etiology (causes of cancer) Healthy eating and active living Screening and diagnosis Treatment Survivorship Health equity

Research Grants: for Independent Investigators at any career stage Purpose: To fund exploratory research to develop research methodologies, establish feasibility, or pilot test high-risk/high-reward research across the research continuum. Funding: 2 years with $125K a year direct costs, plus 20% allowable indirect costs Deadlines: April 1 and Oct. 15 Research Scholar Grants: for Investigators within the first 10 years of an initial independent research career or full-time faculty appointment

Lung cancer

Venture philanthropy Basic research Translational research Clinical research Early career investigators

This fund appears to have a number of programs that support basic, translational, clinical research with an emphasis on supporting researchers from across east Asia and India. Their BRACE Award Venture Competition provides support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into the clinic, with the ultimate goal of improving outcomes for patients affected by cancer globally. Application processes unclear

Glioblastoma multiforme Brain cancer Translational research Clinical research Undergraduate research

funds cutting-edge research that will improve diagnostics and treatment options for patients with brain cancer.

Enterics, Diagnostics, Genomics, Epidemiology, Immunotherapies

Usually focuses on tackling infectious diseases in developing countries but invests in cancer research immunotherapies if benefits can translate to infectious disease

Brain tumors Immunotherapy Imaging Diagnostics

Includes Sontag Foundation, James S. McDonnell Foundation, American Brain Tumor Association. The collaborative has issued four ad hoc RFPs since 2005 with the most recent in 2018, It's possible they could issue another in the future. Hideo Okada and Charles Wilson at UCSF are on the advisory board.

Translational research Difficult to treat cancers pancreatic cancer ovarian cancer glioblastoma acute myelogenous leukemia,

Low probability in short term but the foundation plans to add further research institutes to its network. IGI could possibly explore opportunities to plug in to the network in the future through UCSF if they are able to obtain an invitation to submit to the foundation. William and Alice Goodwin endowed with a $250 million pledge BTC funds collaborative, multidisciplinary research by teams from five major U.S. cancer centers. Partners are Dana-Farber Cancer Institute, The Sidney Kimmel Compreh

Tumor biology, genetics, prevention, treatment, metastasis RFP for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. They provide funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since its founding in 1993 by Evelyn H. Lauder, BCRF has raised more than a billion dollars to fuel its mission to be the end of breast cancer.

Venture philanthropy

BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society. BrightEdge propels patient-centric solutions by accelerating ACS’s mission.

Ageing/cancer, cancer cell plasticity, cancer inequities, chemotherapy-induced neurotoxicities, early-onset cancers, obesity & physical activity/cancer, retrotransposable elements, solid tumors in children, t-cell receptors

Global funding initiative founded by the U.S. National Cancer Institute and Cancer Research UK *Will announce a new set of challenges in 2025, at which point applications will open again.

Immunotherapy Clinical research, fellowships, grants, awards

Focuses on immunotherapy exclusively. Believes all cancer will eventually be treated immunotherapeutically.

Stem cell research

Funder collaborative between the American Cancer Society and the Lisa Dean Moseley Foundation to rapidly accelerate scientific discovery of cancer stem cell research. It appears this fund may have been spent since the pledged $9M was fulfilled. Unclear if Moseley will renew.

Rare cancers Single cell biology Breast cancer Imaging Population-based research Open science STEM equity

Multiple grants to various institutions including the Dana Farber Cancer Institute and....under their Central Science, Single Cell Biology, Imaging, Racial Equity, Rare as One and Open Science programs

Clinical trials/ research Drug discovery Patient Care

Hasn't given in higher ed outside of University of Virginia and MIT in recent years

Postdoctoral fellowships Early career investigators Pediatric cancer Quantitative biology Basic research Translational research Clinical research

Early career-focused funder. Priorities include the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. Fellowships are $300K over 4 years

Clinical research only

Particularly welcomes innovative, small-scale, short-term projects

2/3 of grants go to cancer research for project support of 1 year. 1/3 of grants are made to the Pardee Cancer Treatment Funds Post-docs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at non-profit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure. Medical Committee of specialists manage the application process.

N/A

The Milken Institute’s FasterCures, is dedicated to lowering the barriers to medical innovation and helping funders maximize their philanthropic impact. Development officers can leverage their findings to engage donors more effectively. FasterCures provides white papers, podcasts and videos with medical experts, and policy issue briefs like “A Call to Action for Diversity in Clinical Trials.” Also, home to the Research Acceleration and Improvement Network, which consists of foundations i

Medical Research, Fibrolamellar Hepatocellular Carcinoma, Translational

Prefer to support promising projects less likely to get traditional funding Prioritize seed funding of projects with potential long-term payoffs Avoid funding redundant efforts or displacing existing funding sources.

Medical Research Fellowships

In addition to funding grants and fellowships solely for colon and rectal cancer research, FCC trains researchers to become colorectal cancer advocates through its Research Advocacy Training and Support Program. $1M in research funding to date, seem to fund only one or two research projects a year.

Vaccine and Infectious Disease Clinical Research Public Health (reduce incidence and mortality from cancer and other diseases) Human Biology Basic Science

Fred Hutchinson Cancer Center is an independent organization that serves as UW Medicine's cancer program. Total Grants in 2021: $552K

Fund II makes the list because the IP report credits the foundation with making large grants to Susan G. Komen and the Prostate Cancer Foundation, in both cases to address disparities in breast cancer and prostate cancer in Black men and women. Fund II and its founder Robert Smith are PGSI managed prospects. Smith has given $4.5M to the university.

N/A - see notes

This funder is listed in the IP cancer report as a Medical Research Funder but they do not appear to have any biomedical grant program. Searches for cancer in their grants database turn up no results. Funder is likely Colorado focused. Unclear why it made the report. NOT A PROSPECT.

Clinical trials - phase I and II for any cancer type

Supports the Leukemia and Lymphoma Society's Dare to Dream Project.

Clinical research Diversity in clinical trials Diversity in STEM Cell therapy Drug discovery Immunotherapy Biotechnology

The foundation supports programs designed to advance scientific knowledge; enhance health outcomes; and build strong communities. Special emphasis is directed toward creating career pathways for underserved transitional-aged youth and adults, in growing sectors like biotechnology

Diagnostics Personalized medicine

The foundation lists multiple grants made through their Patient Care program to support projects that advance cancer diagnostics, including for projects that employ genomic methods to develop personalized therapeutics.

Only funds the Jonsson Comprehensive Cancer Center at UCLA.

Basic research Clinical research Health policy Public health Public understanding of science

Funder of the Lasker awards which recognizes significant contributions to biomedical science, clinical research, and public service.

Crohn's disease

The foundation's Crohn's disease program includes sub-programs in prevention (root causes), diagnostics, therapeutics (including precision therapies), and disease biology.

Health disparities and inequities

Basic research Clinical research Vaccines Bioinformatics

Lyda Hill Philanthropies, which includesthe Lyda Hill Foundation and personal giving of Lyda Hill(Giving Pledge signer), looks to fund benchmark and early-stage discovery science and favors projects and organizations that work in her preferred geographic and interest areas (such as cancer). Miss Hill aims to make investments that encourage collaboration, take calculated risks and seek to solve big problems. She is willing to fund and support early-stage and emerging science and scientists. She m

Lymphoma

Pancreatic cancer

Immunotherapy Health Disparities and Inequities Population-based research Early career investigators Drug discovery Cancer centers Metastasis Immuno-oncology Artificial intelligence

Established in 2017 by British billionaire Alexander Knaster who has pledged more than $650M The Mark Foundation operates multiple grant programs designed to impact different areas of cancer research including career development, drug discovery, research collaborations, centers and partnerships. They also fund across the continuum, from basic to translational to clinical, as well as population-based research and health disparity work. Total Assets (2021): $107.5M Total Giving (2021): $37M La

melanoma detection, prognostication, treatment, fellowships, early career research

Melanoma

Venture philanthropy

Raised a $100 million investment fund and $26 million in donations to support early stage research at the Dana Farber Cancer Institute

In June 2022, the Novartis US Foundation provided grants totaling $17.7 million over 10 years to co-create clinical trial centers of excellence at three historically Black medical colleges.

Immunotherapy

Has an early career award but not clear what the funding mechanism is. There may not be an opportunity here.

Immunotherapy

The institute focuses on “high-risk, high-reward” research projects in four key areas that hold the most promise to advance immunotherapy — chimeric antigen receptor (CAR) T-cell therapy, checkpoint inhibitors, tumor antigen discovery, and tumor microenvironment. The institute disbursed $35 million in research grants to domestic organizations in the fiscal year ending December 2019

Multiple myeloma Translational research Early career investigators

Rodger Riney was the founder of Scottrade which was acquired by TD Ameritrade. Riney has been diagnosed with multiple myeloma. The foundation awards grants to medical and research institutions working on the development, testing and approval of new, less toxic and more effectve therapies for multiple myeloma and related cancers. Riney supports early career myeloma researchers through two annual award programs administered by the International Myeloma Society: the Career Development Award and th

Population-based research Pediatric Cancer

Clinical research to evaluate new drugs, novel treatment, basic science research Genomic research

PCF has awarded more than 2,200 projects that offer hope for improving outcomes in patients with prostate cancer. These high-impact projects include clinical research to evaluate new drugs, novel treatment strategies for prostate cancer and basic scientific research to better understand the biology of prostate cancer. -- Challenge Awards: Ranging from $300,000 to $1,500,000 per year for 3 years, these awards will cover direct costs of the research. Teams may be assembled from one institution, o

Pediatric cancer

Supports the Leukemia and Lymphoma Society's Dare to Dream Project.

Not sure how to deal with this one but including because it was featured in the report. Small family foundation but gave $8M to St. Johns Health in Santa Monica for clinical research in immunotherapy and precision genomic medicine.

Brain cancer

Distinguished Scientist Award - support for early career investigators pursing high-risk projects at a critical stage in their research. Sontag Innovation Fund - makes loans and equity investments to advance promising therapeutics, diagnostics, medical devices & other technologies.

Population-based research Pediatric Cancer

Racial equity in clinical trials Cancers that disproportionately affect BIPOC

recruitment and retention of BIPOC patients in cancer clinical trials

Science education Underserved populations healthcare Endowed research funds Scholarships CRISPR

The Foundation does not provide funding for individual research projects and prefers to focus its project funding at New York City hospitals and research centers. The Foundation plans to make more grants in the area of preventive healthcare in the next few years.

Health disparities and inequities Graduate research

Training Researchers to Eliminate Disparities program provides grants to graduate students seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups, specifically among minority populations.

Basic research Translational research Drug Discovery

Founded in 1993 by ESPN and the late Jim Valvano the V Foundation for Cancer Research currently awards five types of grants to support fundamental (basic) or translational research, as well as projects that advance research processes such as clinical trial identification, outreach and enrollment. --V Scholar Grant: Three-year grant of $200,000 per year. It supports young tenure-track faculty by funding projects that are either laboratory-based fundamental research or translational research.

Medical Research Funder